180 related articles for article (PubMed ID: 31513463)
1. Development of a High-Throughput Fluorescence Polarization Assay to Detect Inhibitors of the FAK-Paxillin Interaction.
Marlowe T; Alvarado C; Rivera A; Lenzo F; Nott R; Bondugji D; Montoya J; Hurley A; Kaplan M; Capaldi A; Cance W
SLAS Discov; 2020 Jan; 25(1):21-32. PubMed ID: 31513463
[TBL] [Abstract][Full Text] [Related]
2. Development of a Fragment-Based Screening Assay for the Focal Adhesion Targeting Domain Using SPR and NMR.
Alvarado C; Stahl E; Koessel K; Rivera A; Cherry BR; Pulavarti SVSRK; Szyperski T; Cance W; Marlowe T
Molecules; 2019 Sep; 24(18):. PubMed ID: 31540099
[TBL] [Abstract][Full Text] [Related]
3. FAK displacement from focal adhesions: a promising strategy to target processes implicated in cancer progression and metastasis.
Antoniades I; Kyriakou M; Charalambous A; Kalalidou K; Christodoulou A; Christoforou M; Skourides PA
Cell Commun Signal; 2021 Jan; 19(1):3. PubMed ID: 33413438
[TBL] [Abstract][Full Text] [Related]
4. The Chlamydia effector TarP mimics the mammalian leucine-aspartic acid motif of paxillin to subvert the focal adhesion kinase during invasion.
Thwaites T; Nogueira AT; Campeotto I; Silva AP; Grieshaber SS; Carabeo RA
J Biol Chem; 2014 Oct; 289(44):30426-30442. PubMed ID: 25193659
[TBL] [Abstract][Full Text] [Related]
5. Spatial arrangement of LD motif-interacting residues on focal adhesion targeting domain of Focal Adhesion Kinase determine domain-motif interaction affinity and specificity.
Gupta AB; Mukherjee S; Pan CQ; Velazquez-Campoy A; Sivaraman J; Low BC
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129450. PubMed ID: 31676296
[TBL] [Abstract][Full Text] [Related]
6. Recognition of LD motifs by the focal adhesion targeting domains of focal adhesion kinase and proline-rich tyrosine kinase 2-beta: Insights from molecular dynamics simulations.
Michael E; Polydorides S; Promponas VJ; Skourides P; Archontis G
Proteins; 2020 Aug; ():. PubMed ID: 32776636
[TBL] [Abstract][Full Text] [Related]
7. NMR solution structure of the focal adhesion targeting domain of focal adhesion kinase in complex with a paxillin LD peptide: evidence for a two-site binding model.
Gao G; Prutzman KC; King ML; Scheswohl DM; DeRose EF; London RE; Schaller MD; Campbell SL
J Biol Chem; 2004 Feb; 279(9):8441-51. PubMed ID: 14662767
[TBL] [Abstract][Full Text] [Related]
8. Altering FAK-paxillin interactions reduces adhesion, migration and invasion processes.
Deramaudt TB; Dujardin D; Noulet F; Martin S; Vauchelles R; Takeda K; Rondé P
PLoS One; 2014; 9(3):e92059. PubMed ID: 24642576
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.
Wangpu X; Lu J; Xi R; Yue F; Sahni S; Park KC; Menezes S; Huang ML; Zheng M; Kovacevic Z; Richardson DR
Mol Pharmacol; 2016 May; 89(5):521-40. PubMed ID: 26895766
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional insights into the interaction between the Cas family scaffolding protein p130Cas and the focal adhesion-associated protein paxillin.
Zhang C; Miller DJ; Guibao CD; Donato DM; Hanks SK; Zheng JJ
J Biol Chem; 2017 Nov; 292(44):18281-18289. PubMed ID: 28860193
[TBL] [Abstract][Full Text] [Related]
11. Structural and mechanistic insights into the interaction between Pyk2 and paxillin LD motifs.
Vanarotti MS; Miller DJ; Guibao CD; Nourse A; Zheng JJ
J Mol Biol; 2014 Dec; 426(24):3985-4001. PubMed ID: 25174335
[TBL] [Abstract][Full Text] [Related]
12. Micropillar arrays as potential drug screens: Inhibition of micropillar-mediated activation of the FAK-Src-paxillin signaling pathway by the CK2 inhibitor CX-4945.
Kim J; Choi WJ; Moon SH; Jung J; Park JK; Kim SH; Lee JO
Acta Biomater; 2015 Nov; 27():13-20. PubMed ID: 26318800
[TBL] [Abstract][Full Text] [Related]
13. Engineering Synthetic Antibody Inhibitors Specific for LD2 or LD4 Motifs of Paxillin.
Nocula-Lugowska M; Lugowski M; Salgia R; Kossiakoff AA
J Mol Biol; 2015 Jul; 427(15):2532-2547. PubMed ID: 26087144
[TBL] [Abstract][Full Text] [Related]
14. Minimal features of paxillin that are required for the tyrosine phosphorylation of focal adhesion kinase.
Wade R; Vande Pol S
Biochem J; 2006 Jan; 393(Pt 2):565-73. PubMed ID: 16253116
[TBL] [Abstract][Full Text] [Related]
15. Molecular recognition of leucine-aspartate repeat (LD) motifs by the focal adhesion targeting homology domain of cerebral cavernous malformation 3 (CCM3).
Li X; Ji W; Zhang R; Folta-Stogniew E; Min W; Boggon TJ
J Biol Chem; 2011 Jul; 286(29):26138-47. PubMed ID: 21632544
[TBL] [Abstract][Full Text] [Related]
16. Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding.
Brown MC; Perrotta JA; Turner CE
J Cell Biol; 1996 Nov; 135(4):1109-23. PubMed ID: 8922390
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of paxillin LD4 destabilizes helix formation and inhibits binding to focal adhesion kinase.
Bertolucci CM; Guibao CD; Zheng JJ
Biochemistry; 2008 Jan; 47(2):548-54. PubMed ID: 18092823
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.
Heinhuis B; Koenders MI; van den Berg WB; Netea MG; Dinarello CA; Joosten LA
J Biol Chem; 2012 Feb; 287(8):5733-43. PubMed ID: 22203669
[TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine phosphatase 1B targets focal adhesion kinase and paxillin in cell-matrix adhesions.
González Wusener AE; González Á; Perez Collado ME; Maza MR; General IJ; Arregui CO
J Cell Sci; 2021 Oct; 134(20):. PubMed ID: 34553765
[TBL] [Abstract][Full Text] [Related]
20. p190RhoGEF (Rgnef) promotes colon carcinoma tumor progression via interaction with focal adhesion kinase.
Yu HG; Nam JO; Miller NL; Tanjoni I; Walsh C; Shi L; Kim L; Chen XL; Tomar A; Lim ST; Schlaepfer DD
Cancer Res; 2011 Jan; 71(2):360-70. PubMed ID: 21224360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
